Trial Profile
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 29 Mar 2024
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary) ; Ethambutol (Primary) ; Rifampicin (Primary)
- Indications Mycobacterium avium complex infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms MAC2v3
- 16 Feb 2023 Results (n=228 )assessing Patient-reported symptom and health-related quality of life validation and responsiveness during the first 6 months of treatment , published in the Chest
- 18 Jan 2023 Planned End Date changed from 28 Feb 2023 to 28 Feb 2025.
- 18 Jan 2023 Planned primary completion date changed from 28 Feb 2023 to 28 Feb 2025.